Bolt Biotherapeutics annual net debt
2020
2021
2022
2023
2024
2025
Bolt Biotherapeutics Net Debt Growth & History (BOLT)
Bolt Biotherapeutics's net debt was $11.3M for fiscal 2025.
View full Bolt Biotherapeutics company overviewBolt Biotherapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $11.3M | −$6.7M | −37.49% |
| 2024 | 2024-12-31 | $18.0M | $8.6M | +91.35% |
| 2023 | 2023-12-31 | $9.4M | −$4.0M | −29.61% |
| 2022 | 2022-12-31 | $13.4M | $16.4M | — |
| 2021 | 2021-12-31 | −$3.0M | −$8.4M | — |
| 2020 | 2020-12-31 | $5.3M | — | — |
Bolt Biotherapeutics quarterly net debt
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $8.8M | −$5.8M | −39.90% |
| Q1 2026 | 2026-03-31 | $10.7M | −$5.6M | −34.43% |
| Q4 2025 | 2025-12-31 | $11.3M | −$6.7M | −37.49% |
| Q3 2025 | 2025-09-30 | $5.8M | −$3.0M | −33.76% |
| Q2 2025 | 2025-06-30 | $14.6M | $1.9M | +14.92% |
| Q1 2025 | 2025-03-31 | $16.3M | $1.0M | +6.62% |
| Q4 2024 | 2024-12-31 | $18.0M | $8.6M | +91.35% |
| Q3 2024 | 2024-09-30 | $8.8M | −$2.9M | −24.67% |
| Q2 2024 | 2024-06-30 | $12.7M | $4.7M | +58.20% |
| Q1 2024 | 2024-03-31 | $15.3M | $8.1M | +112.10% |
| Q4 2023 | 2023-12-31 | $9.4M | −$4.0M | −29.61% |
| Q3 2023 | 2023-09-30 | $11.7M | −$927,000 | −7.34% |
| Q2 2023 | 2023-06-30 | $8.0M | $7.7M | +2806.16% |
| Q1 2023 | 2023-03-31 | $7.2M | $27.9M | — |
| Q4 2022 | 2022-12-31 | $13.4M | $16.4M | — |
| Q3 2022 | 2022-09-30 | $12.6M | $11.3M | +885.48% |
| Q2 2022 | 2022-06-30 | $276,000 | $33.1M | — |
| Q1 2022 | 2022-03-31 | −$20.6M | $64.1M | — |
| Q4 2021 | 2021-12-31 | −$3.0M | −$8.4M | — |
| Q3 2021 | 2021-09-30 | $1.3M | — | — |
| Q2 2021 | 2021-06-30 | −$32.8M | — | — |
| Q1 2021 | 2021-03-31 | −$84.8M | — | — |
| Q4 2020 | 2020-12-31 | $5.3M | — | — |
Bolt Biotherapeutics net debt trends
Over the last five fiscal years, Bolt Biotherapeutics's net debt increased from $5.3M to $11.3M, a change of $5.9M. The latest reported quarter, Q2 2026, shows $8.8M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Bolt Biotherapeutics source filings ↗